I found it fitting that the first time Congress got to question the entire quartet of the most powerful tech CEOs, none were actually in the room.The distance didn’t just free them from the sweaty scrum of camera people, protesters, press tables, and face-to-face questioning from legislators enjoying the home-court advantage.
After reviewing the device and reams of data presented by Philip Morris, the agency decided that although Iqos isn’t risk-free, it was “appropriate for the protection of the public health” because the devices had “fewer or lower levels of some toxins.” The authorization doesn’t mean the regulator approves of the device or thinks it’s safe; it just means the FDA believes Iqos isn’t more dangerous than regular cigarettes.
Some kids who started vaping had no idea e-cigarettes even contained nicotine, says Yvonne Prutzman, also a program director at the National Cancer Institute.“With vaping everything flips on its head,” says Sharon Levy, director of the Adolescent Substance Use and Addiction Program at Boston Children’s Hospital.
San Francisco city officials voted unanimously on Tuesday to suspend the sale and delivery of electronic cigarettes until the products are approved by the Food and Drug Administration. In 2018, the FDA warned e-cigarette companies to stop marketing to children and proposed restricting the sale of flavored vaping products to minors.
Juul Sheds Its Anti-Smoking Cred and Embraces Big TobaccoJames Monsees, right, and Adam Bowen, founders of e-cigarette manufacturer Juul.Axel Heimken/Getty ImagesJuul’s deal to accept a big investment from the maker of Marlboro cigarettes will snuff out its chance to take the high road with critics, but it will buy the embattled e-cigarette company time and credibility with regulators.Juul said on Thursday it had accepted a $12.8 billion cash investment from Altria, one of the nation’s largest cigarette makers, for a 35 percent stake that values the three-year-old startup at $38 billion, according to Wells Fargo.It’s tempting to see the financial tie to big tobacco as Juul selling out.
Now, recent data, like a report from the Centers for Disease Control and Prevention showing that 2.1 million middle- and high-school students used e-cigarettes in 2017, is prompting the agency to rethink its position.“The FDA won’t tolerate a whole generation of young people becoming addicted to nicotine as a tradeoff for enabling adults to have unfettered access to these same products,” he said.Gottlieb’s offensive seems primarily aimed at Juul, the most popular of the e-cigarettes, with an estimated 70 percent share of the retail market according to Nielsen data.